QT
ARQT icon

Quantbot Technologies’s Arcutis Biotherapeutics ARQT Stock Holding History

Quantbot Technologies’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7K Sell
921
-76
-8% -$1.94K ﹤0.01% 1484
2025
Q4 		$29K Sell
997
-7,641
-88% -$196K ﹤0.01% 1548
2025
Q3 		$163K Sell
8,638
-1,678
-16% -$26.5K ﹤0.01% 1354
2025
Q2 		$145K Buy
+10,316
New +$145K ﹤0.01% 1313
2024
Q2 		– Sell
-12,200
Closed -$121K – 1419
2024
Q1 		$121K Buy
+12,200
New +$91.1K 0.01% 1127
2023
Q1 		– Sell
-14,500
Closed -$215K – 1528
2022
Q4 		$215K Buy
+14,500
New +$253K 0.02% 870
2022
Q2 		– Sell
-2,300
Closed -$44K – 1683
2022
Q1 		$44K Buy
+2,300
New +$38.9K ﹤0.01% 1223

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return